Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment

NCT01763190 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb